Home » EDot.com Announces Term Sheet to Acquire NanoViricide
EDot.com Announces Term Sheet to Acquire NanoViricide
EDot.com announced the execution of a definitive term sheet to acquire 100 percent of the common stock of NanoViricide, a company engaged in the development of targeted nanomedicines that act like molecular Trojan horses to combat various viral infections, including HIV, HCV, Herpes, Asian (bird) Flu and Influenza.
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May